Study: Tumors grow larger in female fruit flies than males. Here’s what that could mean for humans
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-May-2025 06:08 ET (1-May-2025 10:08 GMT/UTC)
A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key regulatory decision by a U.S. Food and Drug Administration committee. The decision greenlights a new biomarker endpoint, minimal residual disease, for accelerated drug approval in multiple myeloma, and researchers say it could cut a decade off the drug development process.
(Boston)— Nearly 2 million Americans currently reside in jails or prisons, and another 4 million are involved in the criminal legal system under forms of community supervision such as parole and probation. There is a link between incarceration and chronic health issues. The justice-involved population faces significant chronic health conditions, such as diabetes and high blood pressure, and are more likely to have cancer, infectious diseases, and substance use disorders. Approximately 95% of those incarcerated will return to the community, but are medical providers prepared to serve them?
A new study from Boston University Chobanian & Avedisian School of Medicine finds medical students and residents, nationally, are not being taught to care for the incarcerated or formerly incarcerated despite the millions of potential affected patients.
Different types of cancer have unique molecular ‘fingerprints’ which are detectable in early stages of the disease and can be picked up with near-perfect accuracy by small, portable scanners in just a few hours, according to a study published today in the journal Molecular Cell. The discovery by researchers at the Centre for Genomic Regulation (CRG) in Barcelona sets the foundation for creating new, non-invasive diagnostic tests that detect different types of cancer faster and earlier than currently possible.